. 2020 May 22;42(2):96–106. doi: 10.4082/kjfm.20.0025

Table 3.

Differences in isokinetic strength among groups (P-value)^*

Variable	Group 1			Group 2			Group 3			Group 4			Comparison of groups at the end of treatment
Variable	BT–AT	AT–C	BT–C	BT–AT	AT–C	BT–C	BT–AT	AT–C	BT–C	BT–AT	AT–C	BT–C	1–2	1–3	1–4	2–3	2–4	3–4
IT for Rt. HFS in 60°/s (PT)	0.00^*	0.00^*	0.00^*	0.00^*	0.02^*	0.00^*	0.00^*	0.07	0.00^*	0.00^*	0.01^*	0.00^*	0.10	0.26	0.93	0.62	0.07	0.21
IT for Lt. HFS in 60°/s (PT)	0.00^*	0.01^*	0.00^*	0.00^*	0.01^*	0.00^*	0.00^*	0.04^*	0.00^*	0.00^*	0.03^*	0.00^*	0.02^*	0.07	0.86	0.75	0.01^*	0.06
IT for Rt. HAS in 60°/s (PT)	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.00^*	0.55	0.00^*	0.12	0.48	0.93	0.85	0.11	0.47
IT for Lt. HAS in 60°/s (PT)	0.00^*	0.01^*	0.00^*	0.00^*	0.04^*	0.00^*	0.00^*	0.05^*	0.00^*	0.00^*	0.02^*	0.00^*	0.18	0.57	0.46	0.38	0.02^*	0.31

P<0.05 values are presented in bold.

BT, before treatment; AT, after treatment; C, follow-up; IT, isokinetic testing; Rt., right; Lt., left; HFS, hip flexion strength; HAS, hip abduction strength; PT, peak torque.

P<0.05; by Kruskal-Wallis test.